Current Investment Opportunities

All our investments have a lead investor who invests at the same share price, and receives the same share class as you. We don't charge a membership fee, nor do we take a percentage of any profits. There is also EIS and SEIS tax relief available on most opportunities.


 

26 DAYS TO GO
EIS
Dymag designs and manufactures lightweight carbon composite car and motorcycle wheels for vehicle Original Equipment Manufacturers, racing and the aftermarket. Lead investor Boundary Capital comprises a team of experienced investors and entrepreneurs.
N E W
Hardware
Lead Investor
CAPITAL INVESTED
£154,741
 
  52%
EQUITY OFFERED
6.99%
CAPITAL REQUIRED
£299,999
PRE-MONEY VALUATION
£3,992,002
 
OVERFUNDING 5 DAYS TO GO
EIS
SupaPass is a B2B service, providing technology tools to content owners. Those content owners then market their subscription service to their existing consumer audience. Lead investor Derek Watts is an experienced investor and entrepreneur.
Web & Apps
Lead Investor
CAPITAL INVESTED
£645,796
 
  157%
EQUITY OFFERED
9.02%
CAPITAL REQUIRED
£411,000
PRE-MONEY VALUATION
£4,145,715
 
OVERFUNDING 5 DAYS TO GO
EIS
Dem Dx is a diagnostic support tool for medical professionals that augments clinical diagnoses and helps teach better diagnostic skills. Lead investor Tyhoa Kobler has a background in finance and private equity investing.
Health
Lead Investor
CAPITAL INVESTED
£486,891
 
  108%
EQUITY OFFERED
16.84%
CAPITAL REQUIRED
£450,000
PRE-MONEY VALUATION
£2,222,224
 
12 DAYS TO GO
EIS
Engenie is an electric vehicle charging business focused on providing high power rapid charging facilities for electric cars and buses, catering to consumers and commercial fleet and taxi operators.
Others
Lead Investor
CAPITAL INVESTED
£660,555
 
  66%
EQUITY OFFERED
21.37%
CAPITAL REQUIRED
£1,000,125
PRE-MONEY VALUATION
£3,679,200
 
12 DAYS TO GO
EIS
ePatient Network provides rare disease patients with up-to-date scientific information, community insights and medical research and connects them with clinical trial opportunities through its Raremark platform.
Web & Apps | Health
Lead Investor
CAPITAL INVESTED
£333,324
 
  133%
EQUITY OFFERED
5.88%
CAPITAL REQUIRED
£249,998
PRE-MONEY VALUATION
£3,999,007
 
12 DAYS TO GO
EIS
Re-Vana Therapeutics is a life science spin-out from Queen’s University Belfast. Led by an experienced team of entrepreneurs and scientists, they aim to change the way eye medicines are delivered and mitigate the rising tide of blindness worldwide.
Health
Lead Investor
CAPITAL INVESTED
£859,069
 
  90%
EQUITY OFFERED
44.18%
CAPITAL REQUIRED
£950,056
PRE-MONEY VALUATION
£1,200,444
 
19 DAYS TO GO
SEIS
A spin-off from Hobsons Brewery, iSpaniel has developed an asset tracking solution that uniquely identifies an individual container's location, contents and collection profile in real time. Lead Investor, Ian Hall, has extensive brewery sales experience.
Web & Apps
Lead Investor
CAPITAL INVESTED
£96,500
 
  32%
EQUITY OFFERED
17.00%
CAPITAL REQUIRED
£300,000
PRE-MONEY VALUATION
£1,464,750